Abstract:Introduction: We present a novel method to identify cancer driver genes that jointly examines any number of diverse transcriptomic alterations with the goal to uncover highly recurrent and heterogeneous patterns in 1190 samples across 26 cancer types as part of the PanCancer Analysis of Whole Genomes (PCAWG) of the International Cancer Genome Consortium (ICGC). Motivation: Previous pan-cancer genomic studies have focused on the analysis of somatic mutations as the driver of phenotypic changes. Here, we propose a method to integrate a wide variety of RNA and DNA changes to redefine the concept of driver events and account for the transcriptome’s role in tumorigenesis. PTK2 provides a motivating example, since it has many RNA alterations that correlate with patient survival, such as overexpression, exon-skips, and alternative promoter usage. In our analysis, we integrate an unprecedented amount of various alterations including gene fusions, RNA editing, alternative splicing, expression outliers, alternative promoters, allele specific expression, and somatic mutations. This enables us to also identify mutually exclusive (MutE) and co-occurring (CoO) patterns between different types of alterations within a gene. Methods: Our method has 3 main strengths: flexibility to handle any number or type of alteration, sensitivity to different frequencies of alterations so rare events are not lost in the recurrence analysis, and diversity of ranking such that genes with multiple alterations are prioritized. Our method is summarized in two steps: 1) Identify genes that are both recurrently and heterogeneously altered across many samples by calculating a rank-based score for each gene. 2) Identify MutE and CoO patterns between alteration types for the genes identified in the previous step. To ensure that alterations were comparable, we applied a thresholding model to binarize all alterations for gene-sample pairs, allowing us to account for the properties of the different modalities involved. Step 1 of our method calculates a score for each gene that takes into account: 1) the number of alterations to a gene across all samples, 2) the rarity of each alteration, and 3) how many types of alterations are observed per gene. The score is then used to rank the genes and top genes are considered for MutE and CoO analyses. Results: Our top 100 ranked genes were highly enriched for cancer census genes (adjusted p-value: 2.06e-9), indicating that we identify cancer relevant genes. Our top five ranked cancer census genes were IGF2, ERBB2, RARA, CREBBP, and ARID1A; all of which had at least 4 of 7 possible alterations, showing our scoring method prioritizes genes with diverse alterations. We also found that alternative promoter usage and alternative splicing were highly co-occurring alterations, with PTK2 having the highest co-occurrence between them. In summary, we propose a new method to analyze various RNA disruptions and show it can yield new insights beyond genomic variation. Citation Format: Natalie R. Davidson, PanCancer Analysis of Whole Genomes 3 (PCAWG-3) for ICGC, Alvis Brazma, Angela N. Brooks, Claudia Calabrese, Nuno A. Fonseca, Jonathan Goke, Yao He, Xueda Hu, Andre Kahles, Kjong-Van Lehmann, Fenglin Liu, Gunnar Ratsch, Siliang Li, Roland F. Schwarz, Mingyu Yang, Zemin Zhang, Fan Zhang, Liangtao Zheng. Integrating diverse transcriptomic alterations to identify cancer-relevant genes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 389. doi:10.1158/1538-7445.AM2017-389

Understanding genomic alterations in cancer genomes using an integrative network approach

Functional variomics and network perturbation: connecting genotype to phenotype in cancer

Cancer systems biology: exploring cancer-associated genes on cellular networks

Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data

Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks

Large-scale Integrative Network-Based Analysis Identifies Common Pathways Disrupted by Copy Number Alterations Across Cancers

Introduction: Cancer Gene Networks

Evolving Insights: How DNA Repair Pathways Impact Cancer Evolution

Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution

Neo-Darwinian Principles Exemplified in Cancer Genomics

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Lessons from A Decade of Integrating Cancer Copy Number Alterations with Gene Expression Profiles

Cancer systems biology in the genome sequencing era: Part 2, evolutionary dynamics of tumor clonal networks and drug resistance

Functional Genomic Analysis of Chromosomal Aberrations in a Compendium of 8000 Cancer Genomes

e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks

Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

Integrating Diverse Transcriptomic Alterations To Identify Cancer-Relevant Genes

Interpretation of cancer mutations using a multiscale map of protein systems

A Comprehensive Review of Bioinformatics Tools for Genomic Biomarker Discovery Driving Precision Oncology

Abstract LB014: The role of genetic alterations in metastatic development insights from a large-scale genomic database

Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks